Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

The A.R.R.E.S.T.® Contact Lens Study

NCT: NCT06878118 · ACTIVE_NOT_RECRUITING

NCT IDNCT06878118
StatusACTIVE_NOT_RECRUITING
Start Date2025-07-06
Completion2028-06-01
Sponsornthalmic Pty Ltd (NETWORK)
First posted
Last updated

Brief Summary

The goal of this clinical trial is to learn if contact lenses using Active Reconfiguration in Retinal Encoding of Spatio-Temporal (A.R.R.E.S.T.®) signal technology works to slow down the rate of myopia progression compared to single vision contact lenses in myopic children. The main questions it aims to answer are: Do contact lenses using A.R.R.E.S.T.® technology slow down the rate of axial length growth? Do contact lenses using A.R.R.E.S.T.® technology slow down the rate of increase in myopic refractive error? Researchers will compare contact lenses using A.R.R.E.S.T.® technology to a single vision contact lens. Participants will: Be randomly allocated to wear either contact lenses using A.R.R.E.S.T.® technology or single vision contact lenses. Visit the clinic on seven occasions over a 12 month period.

Frequently Asked Questions

What is The A.R.R.E.S.T.® Contact Lens Study?

The A.R.R.E.S.T.® Contact Lens Study is a clinical trial registered under NCT06878118. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT06878118?

The current status of NCT06878118 (The A.R.R.E.S.T.® Contact Lens Study) is: ACTIVE_NOT_RECRUITING.

When did The A.R.R.E.S.T.® Contact Lens Study start?

The A.R.R.E.S.T.® Contact Lens Study started on 2025-07-06.

Related Devices

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.